What did @drjonesdc actually say?
A chiropractor with 217,000 views on this video warned that GLP-1 medications like tirzepatide and semaglutide slow digestion so much that oral contraceptives "might even not absorb proper," citing "dozens of surprise pregnancies." He recommended backup contraception, including condoms, IUDs, or implants. He also touched on muscle loss, dehydration, and bloating as side effects worth managing, and suggested digestive enzymes and protein intake as responses. The birth control claim was the centerpiece, and it is the one that deserves the most scrutiny.
Does the science back this up?
Partially, but the evidence is weaker than this video implies. The theoretical mechanism is real: GLP-1 receptor agonists delay gastric emptying, which could theoretically reduce peak plasma concentrations of orally administered drugs. A pharmacokinetic study by Flint et al. (2013, Clinical Pharmacokinetics) showed liraglutide delayed gastric emptying and modestly reduced acetaminophen absorption. However, the FDA label for Mounjaro (tirzepatide) does not list oral contraceptive failure as a confirmed clinical interaction, and no large-scale epidemiological study has confirmed elevated unintended pregnancy rates specifically among GLP-1 users on the pill. The "dozens of surprise pregnancies" claim is anecdotal and unverifiable. Semaglutide's prescribing information does note a potential interaction with oral medications, but manufacturers of combined oral contraceptives have not issued formal alerts specific to GLP-1 combinations. The concern is biologically plausible. Calling it proven is a stretch.
What did they get wrong (or right)?
Let's give credit where it is due. The general advice to use backup contraception while on GLP-1 medications is actually in line with cautious clinical practice. The American College of Obstetricians and Gynecologists has not issued a formal warning, but several reproductive endocrinologists have publicly recommended exactly what this creator suggests: switching to non-oral methods like IUDs or implants if you are on a GLP-1 drug. That part is reasonable.
What is not reasonable is the framing. Saying "we've already seen dozens of surprise pregnancies" implies clinical data or a published case series. It does not exist in peer-reviewed literature as of this writing. That is irresponsible language from someone with a quarter million views. The mechanism he describes, where "the pill goes through your system too fast," is also backwards. GLP-1 drugs slow gastric emptying, meaning pills move more slowly, not faster. The absorption problem, if real, is about altered peak concentrations, not accelerated transit. Getting the pharmacology wrong while making a reproductive health claim is a significant error.
The muscle mass loss mention is accurate and well-documented. Wilding et al. (2021, New England Journal of Medicine) noted that a meaningful portion of weight lost on semaglutide included lean mass. Protein intake is a legitimate mitigation strategy supported by clinical guidance from obesity medicine specialists.
What should you actually know?
If you are on an oral contraceptive and a GLP-1 medication, the practical advice to use backup protection is defensible, even if the evidence base is not as solid as this video implies. But your prescribing physician, not a chiropractor's TikTok, should be making that call. Here is what the actual data supports:
- GLP-1 receptor agonists do delay gastric emptying, which is a documented pharmacological effect confirmed across multiple trials.
- The clinical significance of this delay for oral contraceptive efficacy has not been established in randomized controlled trials as of 2024.
- Tirzepatide's FDA label advises patients on oral contraceptives to switch to a non-oral method or use barrier contraception for four weeks after starting therapy and after each dose escalation.
- Muscle loss during GLP-1 therapy is real. Resistance training and adequate protein intake are the evidence-backed responses, not supplements sold through bio links.
- Dehydration monitoring via urine color is a basic but clinically reasonable tip. GLP-1-induced nausea and reduced fluid intake can contribute to dehydration.
One more thing worth naming directly: the creator is a DC, a doctor of chiropractic, not an MD, DO, or pharmacist. That does not make everything he says wrong, but it is relevant context when he is discussing drug-drug interactions and reproductive medicine. Credentials matter when the stakes are a pregnancy.